Hollencrest Capital Management Abb Vie Inc. Transaction History

Hollencrest Capital Management

$2.36 Billion
Q3 2024

A detailed history of Hollencrest Capital Management transactions in Abb Vie Inc. stock. As of the latest transaction made, Hollencrest Capital Management holds 6,221 shares of ABBV stock, worth $1.05 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

6,221

Previous 6,536 4.82%

Holding current value

$1.05 Million

Previous $1.12 Million 9.55%

% of portfolio

0.05%

Previous 0.05%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	SELL	$163.84 - $199.33 $51,609 - $62,788	-315 Reduced 4.82%	6,221 $1.23 Million
Q1 2024 May 01, 2024	SELL	$159.82 - $182.1 $1,598 - $1,821	-10 Reduced 0.15%	6,536 $1.19 Million
Q4 2023 Feb 14, 2024	SELL	$137.6 - $154.97 $963 - $1,084	-7 Reduced 0.11%	6,546 $1.01 Million
Q2 2023 Aug 10, 2023	BUY	$132.51 - $164.9 $20,141 - $25,064	152 Added 2.37%	6,553 $882,000
Q1 2023 May 16, 2023	BUY	$144.61 - $166.54 $8,098 - $9,326	56 Added 0.88%	6,401 $1.02 Million
Q4 2022 Feb 06, 2023	BUY	$138.31 - $165.87 $877,576 - $1.05 Million	6,345 New	6,345 $1.03 Million
Q3 2022 Oct 27, 2022	SELL	$134.21 - $153.93 $13,421 - $15,393	-100 Reduced 1.61%	6,099 $818,000
Q1 2022 Apr 18, 2022	SELL	$131.98 - $163.75 $435,533 - $540,375	-3,300 Reduced 34.74%	6,199 $1.01 Million
Q4 2021 Jan 07, 2022	BUY	$107.43 - $135.93 $160,070 - $202,535	1,490 Added 18.6%	9,499 $1.29 Million
Q3 2021 Oct 13, 2021	BUY	$106.4 - $120.78 $85,120 - $96,624	800 Added 11.1%	8,009 $864,000
Q2 2021 Jul 21, 2021	BUY	$105.21 - $117.21 $21,042 - $23,442	200 Added 2.85%	7,209 $812,000
Q1 2021 Apr 29, 2021	SELL	$102.3 - $112.62 $639,681 - $704,212	-6,253 Reduced 47.15%	7,009 $759,000
Q4 2020 Jan 26, 2021	SELL	$80.49 - $108.67 $7,888 - $10,649	-98 Reduced 0.73%	13,262 $1.42 Million
Q3 2020 Oct 13, 2020	SELL	$85.91 - $100.83 $9,536 - $11,192	-111 Reduced 0.82%	13,360 $1.17 Million
Q2 2020 Jul 16, 2020	BUY	$73.37 - $98.18 $293 - $392	4 Added 0.03%	13,471 $1.32 Million
Q1 2020 May 01, 2020	BUY	$64.5 - $97.79 $54,760 - $83,023	849 Added 6.73%	13,467 $1.03 Million
Q4 2019 Jan 23, 2020	BUY	$72.13 - $90.25 $288 - $361	4 Added 0.03%	12,618 $1.12 Million
Q3 2019 Oct 23, 2019	SELL	$62.98 - $75.72 $24,814 - $29,833	-394 Reduced 3.03%	12,614 $955,000
Q2 2019 Jul 18, 2019	BUY	$65.7 - $83.98 $328 - $419	5 Added 0.04%	13,008 $946,000
Q4 2018 May 09, 2019	BUY	$77.85 - $96.01 $389 - $480	5 Added 0.04%	13,003 $1.2 Million
Q4 2018 Jan 03, 2019	SELL	$77.85 - $96.01 $389 - $480	-5 Reduced 0.04%	12,998 $1.2 Million
Q3 2018 May 09, 2019	BUY	$88.91 - $98.84 $711 - $790	8 Added 0.06%	13,003 $1.05 Million
Q3 2018 Oct 04, 2018	BUY	$88.91 - $98.84 $911,594 - $1.01 Million	10,253 Added 373.92%	12,995 $1.23 Million
Q2 2018 Jul 10, 2018	SELL	$89.78 - $106.23 $55,304 - $65,437	-616 Reduced 18.34%	2,742 $0
Q1 2018 Apr 24, 2018	BUY	$92.01 - $123.21 $368 - $492	4 Added 0.12%	3,358 $318,000
Q4 2017 Jan 19, 2018	SELL	$89.56 - $98.21 $339,969 - $372,805	-3,796 Reduced 53.09%	3,354 $0
Q3 2017 Oct 10, 2017	BUY	$69.85 - $89.22 $499,427 - $637,923	7,150	7,150 $635,000

Others Institutions Holding ABBV

# of Institutions

3,863

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $299B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hollencrest Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Hollencrest Capital Management with notifications on news.

Account

Hollencrest Capital Management Abb Vie Inc. Transaction History